News Medical on MSN20h
Obe-cel demonstrates strong efficacy and safety in treating leukemiaPatients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...
Do you like this game?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback